Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-24-007130

Director acquired 1,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meng Lei Director 2024-01-22 Grant or award +1,500,000 $12.00 $18,000,000 2,717,554 I
Derivatives
Meng Lei Director 2024-01-22 Grant or award · Pre-Funded Warrants (Right to Buy) +1,833,333 $12.00 $21,998,163 1,833,333 I
Loading xslF345X05/ownership.xml…